Skip to main content

Orthocell raising ahead of US push

25/10/2024 - 11:52

Bookmark

Save articles for future reference.

Perth-based biotechnology firm Orthocell has raised $17 million to take its Remplir nerve regeneration product to the world's biggest healthcare market.

X

To read our articles you will need to either login or subscribe.